Apatinib in patients with extensive-stage small-cell lung cancer after second-line or third-line chemotherapy: a phase II, single-arm, multicentre, prospective study
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Apatinib in patients with extensive-stage small-cell lung cancer after second-line or third-line chemotherapy: a phase II, single-arm, multicentre, prospective study
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-16
DOI
10.1038/s41416-019-0583-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Apatinib combined with oral etoposide in patients with platinum-resistant or platinum-refractory ovarian cancer (AEROC): a phase 2, single-arm, prospective study
- (2018) Chun-Yan Lan et al. LANCET ONCOLOGY
- First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
- (2018) Leora Horn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-PD-1 Antibody SHR-1210 Combined with Apatinib for Advanced Hepatocellular Carcinoma, Gastric, or Esophagogastric Junction Cancer: An Open-label, Dose Escalation and Expansion Study
- (2018) Jianming Xu et al. CLINICAL CANCER RESEARCH
- EGFR‐TKIs plus local therapy demonstrated survival benefit than EGFR‐TKIs alone in EGFR‐mutant NSCLC patients with oligometastatic or oligoprogressive liver metastases
- (2018) Tao Jiang et al. INTERNATIONAL JOURNAL OF CANCER
- Apatinib as maintenance therapy in extensive-stage small-cell lung cancer: results from a single-center retrospective study
- (2018) Xiangtao Yan et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Real-world treatment patterns and outcomes of patients with small cell lung cancer progressing after 2 lines of therapy
- (2018) Anna D. Coutinho et al. LUNG CANCER
- Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial
- (2017) Marcello Tiseo et al. JOURNAL OF CLINICAL ONCOLOGY
- Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
- (2017) Lin Tian et al. NATURE
- Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade
- (2017) Martina Schmittnaegel et al. Science Translational Medicine
- Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
- (2016) Jin Li et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial
- (2016) Scott J Antonia et al. LANCET ONCOLOGY
- Randomized phase II–III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial†
- (2015) J.-L. Pujol et al. ANNALS OF ONCOLOGY
- Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study—CALGB 30504 (Alliance)
- (2015) Neal E. Ready et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial
- (2015) Ben J Slotman et al. LANCET
- Topotecan for Relapsed Small-cell Lung Cancer: Systematic Review and Meta-Analysis of 1347 Patients
- (2015) Nobuyuki Horita et al. Scientific Reports
- Small cell lung cancer: Where do we go from here?
- (2014) Lauren Averett Byers et al. CANCER
- Southwest Oncology Group S0802: A Randomized, Phase II Trial of Weekly Topotecan With and Without Ziv-Aflibercept in Patients With Platinum-Treated Small-Cell Lung Cancer
- (2014) Jeffrey W. Allen et al. JOURNAL OF CLINICAL ONCOLOGY
- Relapsed small cell lung cancer: treatment options and latest developments
- (2014) Nobuhiro Asai et al. Therapeutic Advances in Medical Oncology
- Treatment of Small Cell Lung Cancer
- (2013) James R. Jett et al. CHEST
- Efficacy and Safety of Oral Topotecan and Bevacizumab Combination as Second-Line Treatment for Relapsed Small-Cell Lung Cancer: An Open-Label Multicenter Single-Arm Phase II Study
- (2013) David R. Spigel et al. Clinical Lung Cancer
- Third-Line Chemotherapy in Small-Cell Lung Cancer: An International Analysis
- (2013) Demetrios Simos et al. Clinical Lung Cancer
- Apatinib for Chemotherapy-Refractory Advanced Metastatic Gastric Cancer: Results From a Randomized, Placebo-Controlled, Parallel-Arm, Phase II Trial
- (2013) Jin Li et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Study of Bevacizumab in Combination With Chemotherapy in Previously Untreated Extensive-Stage Small-Cell Lung Cancer: Results From the SALUTE Trial
- (2011) David R. Spigel et al. JOURNAL OF CLINICAL ONCOLOGY
- A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease
- (2010) P. Zatloukal et al. ANNALS OF ONCOLOGY
- Prognostic Value of Vascular Endothelial Growth Factor Expression in Patients with Lung Cancer: A Systematic Review with Meta-Analysis
- (2010) Ping Zhan et al. Journal of Thoracic Oncology
- Phase II Study of Cisplatin Plus Etoposide and Bevacizumab for Previously Untreated, Extensive-Stage Small-Cell Lung Cancer: Eastern Cooperative Oncology Group Study E3501
- (2009) Leora Horn et al. JOURNAL OF CLINICAL ONCOLOGY
- Oral second- and third-line lomustine–etoposide–cyclophosphamide chemotherapy for small cell lung cancer
- (2009) Bernard Lebeau et al. LUNG CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search